Related Experiment Video

Updated: Jun 18, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal

Yu Wang1, Yasushi Adachi, Arisa Imsumran

  • 1First Department of Internal Medicine, Sapporo Medical University, W-16 Chuo-ku, Sapporo 060-8543, Japan.

Journal of Gastroenterology
|November 11, 2009
PubMed
Abstract

Insights

This study shows that short hairpin RNA targeting the insulin-like growth factor I receptor (shIGF-IR) effectively inhibits digestive/gastrointestinal cancer growth. Combining shIGF-IR with chemotherapy enhances treatment efficacy in preclinical models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Insulin-like growth factor (IGF)-I receptor (IGF-IR) signaling is crucial for the development and progression of digestive/gastrointestinal cancers.
  • Targeting IGF-IR offers a potential therapeutic strategy for these malignancies.

Purpose of the Study:

  • To evaluate the efficacy of blocking IGF-IR signaling using RNA interference delivered by recombinant adenoviruses.
  • To assess the therapeutic potential of short hairpin RNA targeting IGF-IR (shIGF-IR) in various digestive/gastrointestinal cancer models.

Main Methods:

  • Constructed a recombinant adenovirus expressing shIGF-IR.
  • Assessed the effects of shIGF-IR on signal transduction, proliferation, and apoptosis in colorectal, gastric, pancreatic, esophageal, and liver cancer cell lines.
  • Evaluated shIGF-IR efficacy alone and with chemotherapy in vitro, in mouse xenografts, and on insulin signaling pathways.

Main Results:

  • shIGF-IR effectively blocked IGF-IR expression and signaling without affecting insulin signaling.
  • shIGF-IR suppressed cancer cell proliferation and carcinogenicity while inducing apoptosis in a dose-dependent manner.
  • Combination therapy of shIGF-IR and chemotherapy demonstrated significant efficacy against tumors in vivo and enhanced apoptosis induction in vitro.

Conclusions:

  • shIGF-IR shows promise as a therapeutic agent for digestive/gastrointestinal cancers.
  • Combination of shIGF-IR with chemotherapy may represent a potent therapeutic strategy for treating these cancers.

More Related Videos

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...